We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




World’s First One-Minute Hepatitis C Antibody Test Facilitates Quick Triage

By LabMedica International staff writers
Posted on 21 May 2024
Print article
Image: The INSTI HCV Antibody Test is the world’s first one minute test (Photo courtesy of bioLytical Laboratories)
Image: The INSTI HCV Antibody Test is the world’s first one minute test (Photo courtesy of bioLytical Laboratories)

Rapid and accurate testing is crucial in the fight against Hepatitis C. Having regular access to testing helps ensure the prompt identification of potential Hepatitis C infections and facilitates immediate linkage to care, thus helping to reduce further transmission. Now, the first one-minute Hepatitis C antibody test can prove to be an excellent tool in managing this disease.

The INSTI HCV Antibody Test from bioLytical Laboratories (Richmond, BC, Canada) is the world’s first one-minute test that detects antibodies to the Hepatitis C virus, which are substances released into the bloodstream upon infection. The test includes procedural control for IgG and IgM and can identify HCV genotypes 1 through 6, delivering results in as little as 60 seconds. It is both highly accurate and affordable, designed for ease of use. This fully portable system does not require any additional equipment, enabling healthcare providers to conduct tests in various settings, from clinical laboratories to remote testing locations.

By providing results in one minute or less, the INSTI HCV Antibody Test supports rapid triage and facilitates quick access to treatment. Its quick turnaround is ideal for integration into diverse healthcare workflows. The test is simple to administer via a simple finger prick and requires minimal training, making it adaptable to a variety of settings, including clinics and emergency environments. By eliminating the need for venepuncture, the INSTI HCV Antibody Test reduces delays in treatment and improves the connection to subsequent care and treatment, meeting a critical clinical need.

“Our INSTI HCV Antibody Test provides a rapid and reliable tool to identify hepatitis C cases quickly, helping healthcare professionals test high-risk populations and reduce transmission,” said Robert Mackie, bioLytical CEO.

Related Links:
bioLytical Laboratories

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory QC Panel
Assayed Respiratory Control Panel
New
H.pylori Test
Humasis H.pylori Card

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.